Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Wei Wang

ResearcherPublications, citations & collaboration network

Wei Wang is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 778 works, 22,132 citations, an h-index of 57 and an i10-index of 261.

778
Works
22,132
Citations
57
h-index
261
i10-index

How has Wei Wang's publication output changed over time?

ScholarIQpublication output · 2012–2025

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2025.

1
1
8
1
1
20122018202020222025

What are the most-cited papers on Wei Wang?

ScholarIQmost cited works
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang, Wei‐jie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
The Lancet Oncology. 20204,605 CitationsOPEN ACCESS
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-Jie Guan, Wenhua Liang, Yi Zhao, Heng-rui Liang, Zi‐Sheng Chen, Yimin Li, Xiao-qing Liu, Ru-chong Chen, Chun-li Tang, Tao Wang, Chun‐Quan Ou, Li Li, Ping-Yan Chen, Ling Sang, Wei Wang, Jian-fu Li, Caichen Li, Li-min Ou, Bo Cheng, Shan Xiong, Zheng-yi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chun-liang Lei, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian Ming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nanshan Zhong, Jian-xing He
S4210207896. 20203,773 CitationsOPEN ACCESS
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Chuan Qin, Luo‐Qi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Tao Yu, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang, Dai‐Shi Tian
SSRN Electronic Journal. 2020961 CitationsOPEN ACCESS
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Wei‐jie Guan, Wenhua Liang, Yi Zhao, Hengrui Liang, Zisheng Chen, Yimin Li, Xiaoqing Liu, Ruchong Chen, Chunli Tang, Tao Wang, Chun‐Quan Ou, Li Li, Pingyan Chen, Ling Sang, Wei Wang, Jianfu Li, Caichen Li, Limin Ou, Bo Cheng, Shan Xiong, Zhengyi Ni, Jie Xiang, Yu Hu, Lei Liu, Hong Shan, Chunliang Lei, Yixiang Peng, Li Wei, Yong Liu, Yahua Hu, Peng Peng, Jianming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Linling Cheng, Feng Ye, Shiyue Li, Jin-ping Zheng, Nuofu Zhang, Nanshan Zhong, Jianxing He
medRxiv. 2020650 CitationsOPEN ACCESS
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, Liang Huang, Fankai Meng, Lifang Huang, Na Wang, Xiaoxi Zhou, Hui Luo, Zekai Mao, Xing Chen, Jungang Xie, Jing Liu, Hui Cheng, Jianping Zhao, Gang Huang, Wei Wang, Jianfeng Zhou
Journal of Allergy and Clinical Immunology. 2020475 CitationsOPEN ACCESS

Related on ScholarIQ

Central South University
Institution
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Paper
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Paper
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Paper
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Paper
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Paper
470M+ articles · free account